Literature DB >> 9169781

Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains.

J A Chabalgoity1, J A Harrison, A Esteves, R Demarco de Hormaeche, R Ehrlich, C M Khan, C E Hormaeche.   

Abstract

Fatty acid-binding proteins (FABPs) are candidate molecules for vaccines against several parasitic platyhelminths. A FABP from the cestode Echinococcus granulosus (EgDf1) was expressed in Salmonella vaccine strains as a C-terminal fusion to fragment C of tetanus toxin (TetC) by using expression vector pTECH. The fusion protein was equally expressed in several attenuated vaccine strains derived from bacteria with different genetic backgrounds and different attenuating mutations. Single-dose immunization experiments with the aroA Salmonella typhimurium strain SL3261 carrying the pTECH-EgDf1 construct were conducted with mice, using both the intravenous and the oral routes. Surprisingly, the antibody response to EgDf1 and the antigen-specific cytokine production in spleen cells were stronger in mice immunized orally. Furthermore, immune mouse sera strongly reacted with fixed sections of the worm's larval stage. Analysis of the isotype distribution of the specific anti-EgDf1 antibodies showed similar production of immunoglobulin G1 (IgG1) and IgG2a together with specific IgA antibodies. In addition, stimulation of spleen cells from mice immunized with the different constructs with either Salmonella lysate, TetC, or EgDf1 showed that, together with Th1-related cytokines (gamma interferon and interleukin 2 [IL-2]), significant levels of a Th2 cytokine (IL-5) were produced specifically, indicating a Th2 component to the response to the Salmonella carrier and to the recombinant antigens. Salmonellae expressing the TetC-rEgDfl fusion are currently under evaluation as potential vaccines against E. granulosus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169781      PMCID: PMC175333          DOI: 10.1128/iai.65.6.2402-2412.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Regulation of isotype production by IL-4 and IL-5. Effects of lymphokines on Ig production depend on the state of activation of the responding B cells.

Authors:  S L Tonkonogy; D T McKenzie; S L Swain
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

2.  A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection.

Authors:  J A Chabalgoity; C M Khan; A A Nash; C E Hormaeche
Journal:  Mol Microbiol       Date:  1996-02       Impact factor: 3.501

3.  Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain.

Authors:  E J Tijhaar; Y Zheng-Xin; J A Karlas; T F Meyer; M J Stukart; A D Osterhaus; F R Mooi
Journal:  Vaccine       Date:  1994-08       Impact factor: 3.641

4.  Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.

Authors:  C M Khan; B Villarreal-Ramos; R J Pierce; G Riveau; R Demarco de Hormaeche; H McNeill; T Ali; N Fairweather; S Chatfield; A Capron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  A developmentally regulated gene of Echinococcus granulosus codes for a 15.5-kilodalton polypeptide related to fatty acid binding proteins.

Authors:  A Esteves; B Dallagiovanna; R Ehrlich
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

6.  Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression.

Authors:  P D Murray; D T McKenzie; S L Swain; M F Kagnoff
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

7.  Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.

Authors:  J A Chabalgoity; B Villareal-Ramos; C M Khan; S N Chatfield; R D de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.

Authors:  N M Coulson; M Fulop; R W Titball
Journal:  Vaccine       Date:  1994-11       Impact factor: 3.641

9.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

10.  Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.

Authors:  D J Maskell; K J Sweeney; D O'Callaghan; C E Hormaeche; F Y Liew; G Dougan
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

View more
  11 in total

1.  Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice.

Authors:  M Fraize; M E Sarciron; S Azzouz; N Issaadi; G Bosquet; A F Petavy
Journal:  Parasitol Res       Date:  2005-04-12       Impact factor: 2.289

2.  Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.

Authors:  C Jespersgaard; P Zhang; G Hajishengallis; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.

Authors:  J J Lee; K A Sinha; J A Harrison; R D de Hormaeche; G Riveau; R J Pierce; A Capron; R A Wilson; C M Khan
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Human secretory immune response to fatty acid-binding protein fraction from Giardia lamblia.

Authors:  S M T Hasan; M Maachee; O M Córdova; R Diaz de la Guardia; M Martins; A Osuna
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.

Authors:  Patrícia A E Abreu; Patrícia A Miyasato; Mônica M Vilar; Waldely O Dias; Paulo L Ho; Míriam Tendler; Ana L T O Nascimento
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.

Authors:  S J Ward; G Douce; D Figueiredo; G Dougan; B W Wren
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

8.  Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium.

Authors:  S J Dunstan; C P Simmons; R A Strugnell
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

9.  Direct interaction between EgFABP1, a fatty acid binding protein from Echinococcus granulosus, and phospholipid membranes.

Authors:  Jorge L Porfido; Gabriela Alvite; Valeria Silva; Malcolm W Kennedy; Adriana Esteves; Betina Corsico
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

10.  An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.

Authors:  Anne-Francoise Petavy; Carlos Hormaeche; Samia Lahmar; Hammou Ouhelli; Alejandro Chabalgoity; Thierry Marchal; Samira Azzouz; Fernanda Schreiber; Gabriela Alvite; Marie-Elisabeth Sarciron; Duncan Maskell; Adriana Esteves; Georges Bosquet
Journal:  PLoS Negl Trop Dis       Date:  2008-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.